Summary of the change in the 1.2013 version of Hepatobiliary Cancer guidelined from the 2.2012 version include:
Initial workup and follow-up, including LDH was removed from comprehensive metabolic panel.
Follow-up,imaging was modified:Chest and zbdnominal pelvic imaging.
